Avatrombopag Combined With IST as First-line Treatment for SAA
Clinical trial NCT05720234 · UNKNOWN
Trial details
- NCT number
- NCT05720234
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2023-11-30
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.